<DOC>
	<DOCNO>NCT00219479</DOCNO>
	<brief_summary>It unclear enteral nutrition via feed tube give patient receive enteral Dilantin . Some caregiver hold feeding one hour one hour Dilantin dose insure adequate absorption medication caregiver think feeding need interrupt . Hypothesis : Dilantin level remain therapeutic enteral nutrition give continuously administration enteral Dilantin . The objective study determine Dilantin level enteral feeding give continuous method . Thirty patient study . When Dilantin level therapeutic range 2 consecutive day interrupt feeding ( baseline ) , patient switch continuous feeding uninterrupted medication , 7 day . Dilantin level check daily level become subtherapeutic intravenous ( IV ) bolus Dilantin give enteral dose increase ( dos determine primary caregiver ) . Serum albumin measure baseline begin end week , order calculate free Dilantin .</brief_summary>
	<brief_title>Dilantin Levels With Continuous Delivery Enteral Feedings - A Pilot Study</brief_title>
	<detailed_description>Rationale : It unclear enteral nutrition via feed tube give patient receive enteral Dilantin . Some caregiver hold feeding one hour one hour Dilantin dose insure adequate absorption medication caregiver think feeding need interrupt . Both method use institution , although interrupt method recommend Clinical Nutrition Service . Interrupting feeding obvious disadvantage patient receive less hour feed require nurse intervention . Key Objectives : To determine change Dilantin level enteral feeding give continuous method . Study Population : 30 patient already Dilantin seizure prophylaxis already receive enteral nutrition interrupt method stable , therapeutic Dilantin level . Major Inclusion Criteria : 1. Dilantin seizure prophylaxis ( dose determine primary caregiver ) therapeutic Dilantin level 2. receive enteral nutrition interrupt method goal feed rate ; 3. age &gt; 18 4. feeding tube proper position , restriction type feed tube ( nasogastric , nasoduodenal , gastrostomy , jejunostomy ) , Dilantin enteral feeding must give tube . Major Exclusion Criteria : 1. history seizure 2. albumin infusion necessary study period 3. anticipation feeding need hold 4 hour time 4 . Patients maintain stable Dilantin level ( &lt; 25 % variability ) interrupt method feeding ; 5 ) inability obtain consent patient spokesperson . Allocation Groups : patient switch baseline method feeding ( interrupt ) continuous feed . Procedures : When Dilantin level therapeutic range 2 consecutive day interrupt feeding ( baseline ) , patient switch continuous feeding uninterrupted medication , 7 day . Dilantin level check daily level become subtherapeutic IV bolus Dilantin give enteral dose increase ( dos determine primary caregiver ) . Serum albumin measure baseline begin end week , order calculate free Dilantin . Risks Discomforts : 1. subtherapeutic Dilantin level , closely follow ; 2. seizure , patient discontinue occur ; 3. venipuncture 10 Dilantin level 3 serum albumin determination ( minimum blood test 0.4 cc ) . Confidentiality : Subjects identify initial study number .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>1 . On Dilantin seizure prophylaxis ( dose determine primary caregiver ) therapeutic Dilantin level 2 . Receiving enteral nutrition interrupt method goal feed rate 3 . Age &gt; 18 4 . Feeding tube proper position , restriction type feed tube ( nasogastric , nasoduodenal , gastrostomy , jejunostomy ) , Dilantin enteral feeding must give tube 1 . History seizures 2 . Albumin infusion necessary study period 3 . Anticipation feeding need hold 4 hour time 4 . Patients maintain stable Dilantin level ( &lt; 25 % variability ) interrupt method feed 5 . Inability obtain consent patient spokesperson</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>seizure prophylaxis</keyword>
	<keyword>enteral nutrition</keyword>
</DOC>